Volgograd Scientists Have Developed a Drug in Diabetic and Obesity Capsules.
3 Articles
3 Articles
Dr. Denis Babkov, Director of Scientific Activities of Volgograd State Medical University, reported on the development and initiation of clinical trials of a drug in type II diabetes mellitus and obesity capsules. The new product was called "Dipiron" and was different from the existing foreign counterparts by giving RIA "New News" in a convenient form. "In contrast to the "Ozempic", which mimics the GPP-1 hormone, "Dipiaron", using the GPR119 re…
Scientists at Volgograd State Medical University have embarked on a second phase of clinical research into the innovative domestic drug Dypiaron.
Russian scientists have developed a drug called "Dipiron" in the second type diabetes pods, which in the long run can also be used against obesity, which has already passed the first phase of clinical trials and is available on the website of Volgograd State Medical University.
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
